161 related articles for article (PubMed ID: 8850464)
1. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies.
Ris HB; Altermatt HJ; Nachbur B; Stewart CM; Wang Q; Lim CK; Bonnett R; Althaus U
Lasers Surg Med; 1996; 18(1):39-45. PubMed ID: 8850464
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats.
Krueger T; Pan Y; Tran N; Altermatt HJ; Opitz I; Ris HB
Lasers Surg Med; 2005 Oct; 37(4):271-7. PubMed ID: 16245295
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results.
Ris HB; Altermatt HJ; Inderbitzi R; Hess R; Nachbur B; Stewart JC; Wang Q; Lim CK; Bonnett R; Berenbaum MC
Br J Cancer; 1991 Dec; 64(6):1116-20. PubMed ID: 1764375
[TBL] [Abstract][Full Text] [Related]
4. Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Krueger T; Altermatt HJ; Mettler D; Scholl B; Magnusson L; Ris HB
Lasers Surg Med; 2003; 32(1):61-8. PubMed ID: 12516073
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ
Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737
[TBL] [Abstract][Full Text] [Related]
6. mTHPC-mediated photodynamic diagnosis of malignant brain tumors.
Zimmermann A; Ritsch-Marte M; Kostron H
Photochem Photobiol; 2001 Oct; 74(4):611-6. PubMed ID: 11683042
[TBL] [Abstract][Full Text] [Related]
7. Experimental assessment of photodynamic therapy with chlorins for malignant mesothelioma.
Ris HB; Giger A; Hof VI; Mettler D; Stewart JC; Althaus U; Altermatt HJ
Eur J Cardiothorac Surg; 1997 Oct; 12(4):542-8. PubMed ID: 9370396
[TBL] [Abstract][Full Text] [Related]
8. Correlation of photodynamic activity and fluorescence signaling for free and pegylated mTHPC in mesothelioma xenografts.
Tran N; Krueger T; Pan Y; Yan H; Cheng C; Altermatt HJ; Ballini JP; Borle F; Ris HB; Andrejevic-Blant S
Lasers Surg Med; 2007 Mar; 39(3):237-44. PubMed ID: 17345623
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: optimization of the therapeutic index.
Ris HB; Altermatt HJ; Stewart CM; Schaffner T; Wang Q; Lim CK; Bonnett R; Althaus U
Int J Cancer; 1993 Sep; 55(2):245-9. PubMed ID: 8370622
[TBL] [Abstract][Full Text] [Related]
10. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy.
Braichotte DR; Savary JF; Monnier P; van den Bergh HE
Lasers Surg Med; 1996; 19(3):340-6. PubMed ID: 8923430
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results.
Schouwink H; Rutgers ET; van der Sijp J; Oppelaar H; van Zandwijk N; van Veen R; Burgers S; Stewart FA; Zoetmulder F; Baas P
Chest; 2001 Oct; 120(4):1167-74. PubMed ID: 11591556
[TBL] [Abstract][Full Text] [Related]
12. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light.
Pittet O; Petermann D; Michod D; Krueger T; Cheng C; Ris HB; Widmann C
J Photochem Photobiol B; 2007 Jul; 88(1):29-35. PubMed ID: 17560792
[TBL] [Abstract][Full Text] [Related]
13. Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma.
Opitz I; Krueger T; Pan Y; Altermatt HJ; Wagnières G; Ris HB
Eur Surg Res; 2006; 38(3):333-9. PubMed ID: 16785733
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
15. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
16. Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: correlation with sensitizer uptake, tumor doubling time and tumor histology.
Ris HB; Li Q; Krueger T; Lim CK; Reynolds B; Althaus U; Altermatt HJ
Int J Cancer; 1998 Jun; 76(6):872-4. PubMed ID: 9626355
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
Schouwink H; Ruevekamp M; Oppelaar H; van Veen R; Baas P; Stewart FA
Photochem Photobiol; 2001 Apr; 73(4):410-7. PubMed ID: 11332037
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma.
Reuther T; Kübler AC; Zillmann U; Flechtenmacher C; Sinn H
Lasers Surg Med; 2001; 29(4):314-22. PubMed ID: 11746108
[TBL] [Abstract][Full Text] [Related]
19. mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Horlings RK; Terra JB; Witjes MJ
Lasers Surg Med; 2015 Dec; 47(10):779-87. PubMed ID: 26462858
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic action of meta-tetrahydroxyphenylchlorin (mTHPC) on an ovarian cancer cell line.
Gharehbaghi K; Kubin A; Grusch M; Gharehbaghi-Schnell E; Wierrani F; Jayaram HN; Grunberger W; Szekeres T
Anticancer Res; 2000; 20(4):2647-52. PubMed ID: 10953338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
